The PRPH2 Gene Fundus Albipunctatus Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the PRPH2 gene, which are linked to Fundus Albipunctatus, a rare genetic disorder. This condition is characterized by the presence of numerous small, white or yellow dots scattered across the retina, which can lead to night blindness or delayed dark adaptation, although vision is usually otherwise normal. The test is crucial for accurate diagnosis, enabling targeted management and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the PRPH2 gene and provide a comprehensive understanding of the genetic basis of Fundus Albipunctatus. Conducted in the advanced facilities of DNA Labs UAE, this test represents a significant step forward in the personalized care and management of patients with this rare retinal disorder.
The RDH5 Gene Fundus Albipunctatus Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the RDH5 gene, which are known to cause Fundus Albipunctatus, a rare genetic disorder. This condition is characterized by an abundance of white dots in the retina, leading to night blindness or delayed dark adaptation, though vision can improve in bright light conditions. The RDH5 gene plays a crucial role in the visual cycle, and mutations can disrupt this process, leading to the symptoms observed in affected individuals.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in a laboratory to detect any genetic anomalies associated with the condition. It is particularly valuable for individuals showing symptoms of Fundus Albipunctatus or those with a family history of the disorder, providing crucial information for diagnosis, management, and genetic counseling.
Conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services, the RDH5 Gene Fundus Albipunctatus Genetic Test is priced at 4400 AED. The test is performed under strict quality controls and is interpreted by genetic experts, ensuring accurate and reliable results. This test not only aids in confirming the diagnosis but also helps in understanding the inheritance pattern, which is vital for affected families considering future pregnancies.
The "ROBO3 Gene Gaze Palsy Horizontal with Progressive Scoliosis Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the ROBO3 gene. This gene plays a crucial role in the development of the nervous system, and mutations can lead to Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS), a rare neurological disorder characterized by the inability to move the eyes horizontally and a progressive curvature of the spine. The test is crucial for individuals showing symptoms of HGPPS, as early diagnosis can aid in managing the condition and planning treatment strategies. Priced at 4400 AED, this genetic test offers a comprehensive analysis, providing valuable insights for affected individuals and their families.
The ITPR1 gene Gillespie syndrome genetic test is a specialized diagnostic assessment offered at DNA Labs UAE, designed to detect mutations in the ITPR1 gene that are associated with Gillespie syndrome. Gillespie syndrome is a rare genetic disorder characterized by partial aniridia (absence of the iris), ataxia, and intellectual disability. The condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene is sufficient to cause the disorder.
This test is critical for individuals who exhibit symptoms of Gillespie syndrome or have a family history of the condition, as it provides definitive genetic evidence of the ITPR1 gene mutation. Early and accurate diagnosis through this genetic test can facilitate appropriate management and interventions for affected individuals.
The cost of the ITPR1 gene Gillespie syndrome genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive analysis involved in identifying the genetic mutation, including the collection of a DNA sample, typically through a blood draw or cheek swab, and the subsequent laboratory analysis. Once the test is completed, a detailed report is provided, outlining the findings and offering guidance for further steps.
Given the specialized nature of this test and its importance in the diagnosis and management of Gillespie syndrome, it is a valuable tool for affected families. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results.
The MYOC Gene Glaucoma Open Angle Type 1A Genetic Test is a specific diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MYOC gene, which have been linked to the development of open-angle glaucoma, the most common form of glaucoma. This condition is characterized by the gradual increase in intraocular pressure, leading to optic nerve damage and, if untreated, can result in progressive vision loss. The MYOC gene plays a crucial role in the eye's aqueous humor outflow, and mutations in this gene can lead to its dysfunction, contributing to the development of glaucoma.
This genetic test is particularly important for individuals with a family history of glaucoma or those who have been identified as high-risk based on clinical assessments. Early detection through genetic testing can facilitate timely intervention, potentially slowing or preventing the progression of the disease. The test involves a simple collection of a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the MYOC gene.
Offered at a cost of 4400 AED, the MYOC Gene Glaucoma Open Angle Type 1A Genetic Test at DNA Labs UAE represents a significant step forward in personalized medicine, allowing for targeted risk assessment and management strategies for individuals at risk of developing this challenging eye condition.
The "OPTN Gene Glaucoma Open Angle Type 1E Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the OPTN gene that are associated with open-angle glaucoma type 1E. Open-angle glaucoma is the most common form of glaucoma, characterized by a gradual loss of vision due to damage to the optic nerve, often without early symptoms. The OPTN gene plays a crucial role in the regulation of intraocular pressure and the normal functioning of the optic nerve. Mutations in this gene can lead to impaired ocular fluid drainage, increased eye pressure, and ultimately, optic nerve damage.
This genetic test is a powerful tool for early detection and risk assessment, allowing individuals to understand their susceptibility to developing this form of glaucoma. Early identification of genetic predispositions can lead to proactive monitoring and timely interventions, potentially preserving vision. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic variations in the OPTN gene.
DNA Labs UAE offers this test at a cost of 4400 AED. By providing this service, DNA Labs UAE enables individuals and families to make informed decisions about their eye health and take preventative measures against one of the leading causes of blindness worldwide. It is especially beneficial for those with a family history of glaucoma, as it offers a deeper insight into their genetic risk factors.
The ASB10 Gene Glaucoma Open Angle Type 1F Genetic Test is a specialized diagnostic tool designed to identify mutations in the ASB10 gene, which are implicated in the development of open-angle glaucoma type 1F. Open-angle glaucoma is the most common form of glaucoma, characterized by the gradual loss of vision due to damage to the optic nerve, often without early symptoms. The ASB10 gene plays a crucial role in eye health, and mutations in this gene can significantly increase the risk of developing this type of glaucoma.
This genetic test is particularly important for individuals with a family history of glaucoma or those who are at an increased risk of developing the condition. Early identification of genetic predispositions allows for timely intervention and management strategies to prevent or slow down the progression of glaucoma, preserving vision.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ASB10 Gene Glaucoma Open Angle Type 1F Genetic Test is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the ASB10 gene. Results from this test can provide valuable information for personalized treatment plans and preventive measures for individuals at risk of developing open-angle glaucoma type 1F.
The NTF4 Gene Glaucoma Open Angle Type 1F Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the NTF4 gene, which have been associated with the development of open-angle glaucoma, specifically type 1F. Open-angle glaucoma is the most common form of glaucoma, characterized by the gradual loss of vision due to damage to the optic nerve, often without early symptoms. Mutations in the NTF4 gene can lead to reduced neurotrophin-4 protein levels, which is crucial for the survival of retinal ganglion cells. Identifying mutations in this gene can provide crucial information for the early detection and management of glaucoma, potentially preserving vision.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the NTF4 gene. Results from this test can help healthcare providers develop a more personalized treatment plan for patients at risk of or diagnosed with open-angle glaucoma, focusing on early intervention and tailored management strategies to slow the progression of the disease.
The WDR36 Gene Glaucoma Open Angle Type 1G Genetic Test is a specialized diagnostic assessment offered at DNA Labs UAE, designed to detect mutations in the WDR36 gene, which have been associated with open-angle glaucoma, the most common form of glaucoma. Open-angle glaucoma is characterized by the gradual loss of vision due to damage to the optic nerve, often without early symptoms, making genetic testing a valuable tool for early detection and management.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic variations in the WDR36 gene that are known to increase the risk of developing open-angle glaucoma. Identifying individuals at risk allows for early intervention, potentially slowing the progression of the disease and preserving vision. DNA Labs UAE provides this testing service with a focus on accuracy, confidentiality, and support, offering a crucial resource for those with a family history of glaucoma or individuals experiencing related symptoms.
The CYP1B1 Gene Glaucoma Primary Type 3A Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the CYP1B1 gene that are associated with Primary Congenital Glaucoma (PCG), specifically type 3A. This form of glaucoma is a severe eye condition that typically presents itself in infancy or early childhood, leading to increased intraocular pressure, optic nerve damage, and potentially, loss of vision if left untreated. The CYP1B1 gene plays a critical role in the development of the eye's drainage system; mutations in this gene can disrupt this system, leading to the accumulation of eye fluid and increased pressure.
The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic alterations in the CYP1B1 gene. Identifying these mutations can provide valuable information for the early diagnosis and management of glaucoma, allowing for timely intervention and a better prognosis for affected individuals. Additionally, this test can be useful for families with a history of Primary Congenital Glaucoma, offering them an opportunity for genetic counseling and informed decision-making regarding family planning. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, contributing to the effective detection and management of glaucoma in susceptible individuals.
